{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:28:51Z","timestamp":1792189731612,"version":"4.4.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["PO1AG14449"],"award-info":[{"award-number":["PO1AG14449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1AG043375"],"award-info":[{"award-number":["RO1AG043375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30AG010161"],"award-info":[{"award-number":["P30AG010161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["PO1 AG107617"],"award-info":[{"award-number":["PO1 AG107617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AG026032"],"award-info":[{"award-number":["R21AG026032"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AG042146"],"award-info":[{"award-number":["R21AG042146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbr.2016.05.030","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T18:48:45Z","timestamp":1463165325000},"page":"54-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Molecular and cellular pathophysiology of preclinical Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"311","author":[{"given":"Elliott J.","family":"Mufson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos D.","family":"Ikonomovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Counts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malek-Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Scheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.05.030_bib0005","first-page":"445","article-title":"Sur les l\u00e9sions et la pathog\u00e9nie de l\u2019\u00e9pilepsie dite essentielle","volume":"12","author":"Blocq","year":"2015","journal-title":"Sem. Med."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1352\/0895-8017(2004)109<126:IAPODI>2.0.CO;2","article-title":"Incidence and prevalence of dementia in elderly adults with mental retardation without down syndrome","volume":"109","author":"Zigman","year":"2004","journal-title":"Am. J. Ment. Retard."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291700009120","article-title":"Down\u2019s syndrome and Alzheimer\u2019s disease: a review","volume":"16","author":"Oliver","year":"1986","journal-title":"Psychol. Med."},{"issue":"44","key":"10.1016\/j.bbr.2016.05.030_bib0020","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5079","key":"10.1016\/j.bbr.2016.05.030_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","article-title":"Production of the Alzheimer amyloid beta protein by normal proteolytic processing","volume":"258","author":"Shoji","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1750-3639.1993.tb00725.x","article-title":"Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer\u2019s disease and Lewy body dementias","volume":"3","author":"Trojanowski","year":"1993","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.bbr.2016.05.030_bib0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp-2012-303144","article-title":"Therapeutic strategies for tau mediated neurodegeneration","volume":"84","author":"Yoshiyama","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(12)70307-1","article-title":"A presenilin 1 mutation in the first case of Alzheimer\u2019s disease","volume":"12","author":"Muller","year":"2013","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2014.06.005","article-title":"A presenilin 1 mutation in the first case of Alzheimer\u2019s disease: revisited","volume":"10","author":"Rupp","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"5054","key":"10.1016\/j.bbr.2016.05.030_bib0055","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s100480050011","article-title":"Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis","volume":"1","author":"Graeber","year":"1997","journal-title":"Neurogenetics"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004060050027","article-title":"The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections","volume":"248","author":"Moller","year":"1998","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","article-title":"Neuroplasticity failure in Alzheimer\u2019s disease: bridging the gap between plaques and tangles","volume":"24","author":"Mesulam","year":"1999","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0075","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0197-4580(02)00042-8","article-title":"Testing times for the amyloid cascade hypothesis","volume":"23","author":"Hardy","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neurobiolaging.2012.06.014","article-title":"Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals","volume":"34","author":"Sperling","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0085","first-page":"54","article-title":"Preclinical Alzheimer disease-the challenges ahead nature reviews","volume":"9","author":"Sperling","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbr.2016.05.030_bib0095","series-title":"Mild Cognitive Impairment Aging to Alzheimer\u2019s Disease","article-title":"Conceptual overview","author":"Petersen","year":"2003"},{"issue":"17","key":"10.1016\/j.bbr.2016.05.030_bib0100","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2010-1220","article-title":"Neuropathologic alterations in mild cognitive impairment: a review","volume":"19","author":"Markesbery","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2016.05.030_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","article-title":"Braak staging, plaque pathology and APOE status in elderly persons without cognitive impairment","volume":"37","author":"Mufson","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2016.05.030_bib0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neurobiolaging.2016.02.031","article-title":"Protein homeostasis gene dysregulation in pretangle bearing nucleus basalis neurons during the progression of Alzheimer\u2019s disease","volume":"42","author":"Tiernan","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.02.018","article-title":"Preclinical AD Workgroup staging: pathological correlates and potential challenges","volume":"33","author":"Jicha","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: quantification and assessment of synapse change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegeneration"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-011-0884-1","article-title":"Mild cognitive impairment: pathology and mechanisms","volume":"123","author":"Mufson","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737175.2015.995637","article-title":"Advances in the therapy of Alzheimer\u2019s disease: targeting amyloid beta and tau and perspectives for the future","volume":"15","author":"Hampel","year":"2015","journal-title":"Exp. Rev. Neurother."},{"key":"10.1016\/j.bbr.2016.05.030_bib0140","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0145","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","article-title":"The amyloid pathology progresses in a neurotransmitter-specific manner","volume":"27","author":"Bell","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1017\/S1355617710001426","article-title":"Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults","volume":"17","author":"Dowling","year":"2011","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005072-199902000-00010","article-title":"Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta","volume":"58","author":"Thal","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","article-title":"Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections","volume":"1","author":"Braak","year":"1991","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0165","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00294607","article-title":"Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia","volume":"80","author":"Braak","year":"1990","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-2003-5201","article-title":"Conformational changes and truncation of tau protein during tangle evolution in Alzheimer\u2019s disease","volume":"5","author":"Garcia-Sierra","year":"2003","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2016.05.030_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","article-title":"Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment","volume":"37","author":"Mufson","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.bbr.2016.05.030_bib0185","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0195","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1212\/WNL.54.11.2072","article-title":"Age-specific incidence rates of Alzhieimer's disease: the Baltimore longitudinal study of aging","volume":"54","author":"Kawas","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0200","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and preclinical Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0205","first-page":"583","article-title":"Clinical validity of Braak neuropathological staging in the oldest-old","volume":"579\u2013582","author":"Gold","year":"2000","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.bbr.2016.05.030_bib0210","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2016.05.030_bib0215","unstructured":"Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, Neurobiol Aging 18(4 Suppl.) (1997) S1\u20132."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000341273.18141.64","article-title":"Factors associated with resistance to dementia despite high Alzheimer disease pathology","volume":"72","author":"Erten-Lyons","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jchemneu.2011.02.004","article-title":"Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer\u2019s disease","volume":"42","author":"Counts","year":"2011","journal-title":"J. Chem. Neuroanat."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1474-4422(16)00067-3","article-title":"Sex differences in Alzheimer\u2019s disease and other dementias","volume":"15","author":"Mazure","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0235","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.1999.7086","article-title":"Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment","volume":"158","author":"Mufson","year":"1999","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02189115","article-title":"Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia","volume":"246","author":"Bancher","year":"1996","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2016.05.030_bib0245","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles do count when staging disease severity","volume":"66","author":"Nelson","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.05.030_bib0250","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-160365","article-title":"Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elders","author":"Malek-Ahmadi","year":"2016","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneurol.2011.31","article-title":"Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment","volume":"68","author":"Wilson","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbr.2016.05.030_bib0260","doi-asserted-by":"crossref","unstructured":"S.W. Scheff, M.A. Ansari, E.J. Mufson, Relationship between oxidative stress and hippocampal synaptic proteins: evidence for prodromal Alzheimer\u2019s disease Neurobiology of aging (in press) (2016).","DOI":"10.1016\/j.neurobiolaging.2016.02.030"},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbr.2016.05.030_bib0270","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.bbr.2016.05.030_bib0275","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2004-6209","article-title":"Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer\u2019s disease","volume":"6","author":"Pratico","year":"2004","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0285","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers \u2013 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"issue":"7082","key":"10.1016\/j.bbr.2016.05.030_bib0290","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajpath.2015.09.018","article-title":"Synaptic amyloid-beta oligomers precede p-tau and differentiate high pathology control cases","volume":"186","author":"Bilousova","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0300","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.bbr.2016.05.030_bib0305","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","article-title":"Progressive accumulation of amyloid-beta oligomers in Alzheimer\u2019s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins","volume":"277","author":"Pham","year":"2010","journal-title":"FEBS J."},{"issue":"14","key":"10.1016\/j.bbr.2016.05.030_bib0310","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2016.05.030_bib0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","article-title":"Neurodegenerative diseases: expanding the prion concept","volume":"38","author":"Walker","year":"2015","journal-title":"Ann. Rev. Neurosci."},{"issue":"Pt 8","key":"10.1016\/j.bbr.2016.05.030_bib0320","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.bbr.2016.05.030_bib0325","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2174\/15672050113109990157","article-title":"Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition","volume":"10","author":"Negash","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.bbr.2016.05.030_bib0330","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","article-title":"Cognitive reserve","volume":"47","author":"Stern","year":"2009","journal-title":"Neuropsychologia"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2012.03.004","article-title":"Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer\u2019s disease","volume":"34","author":"Arnold","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JAD-2003-5106","article-title":"Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer\u2019s neuropathology","volume":"5","author":"Ikonomovic","year":"2003","journal-title":"J. Alzheimers Dis."},{"issue":"18","key":"10.1016\/j.bbr.2016.05.030_bib0350","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"issue":"1\u20134","key":"10.1016\/j.bbr.2016.05.030_bib0355","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000333122","article-title":"Hippocampal drebrin loss in mild cognitive impairment","volume":"10","author":"Counts","year":"2012","journal-title":"Neuro Degenerative Dis."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0360","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/NEN.0b013e318272caab","article-title":"Hippocampal ProNGF signaling pathways and beta-amyloid levels in mild cognitive impairment and alzheimer disease","volume":"71","author":"Mufson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.05.030_bib0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2015.03.006","article-title":"Hippocampal plasticity during the progression of Alzheimer\u2019s disease","volume":"309","author":"Mufson","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.bbr.2016.05.030_bib0370","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.neurobiolaging.2007.05.005","article-title":"Resistance to Alzheimer\u2019s pathology is associated with nuclear hypertrophy in neurons","volume":"28","author":"Riudavets","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0375","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bbr.2016.05.030_bib0380","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","article-title":"Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease","volume":"64","author":"Ikonomovic","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.bbr.2016.05.030_bib0390","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bbr.2016.05.030_bib0395","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00005072-199709000-00007","article-title":"The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains","volume":"56","author":"Ikonomovic","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0400","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.63.1.49","article-title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","volume":"63","author":"Reisberg","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0405","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0410","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0958-1669(94)90091-4","article-title":"APOE is a major susceptibility gene for Alzheimer\u2019s disease","volume":"5","author":"Roses","year":"1994","journal-title":"Curr. Opin. Biotechnol."},{"issue":"12","key":"10.1016\/j.bbr.2016.05.030_bib0415","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.0b013e318288690c","article-title":"Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI","volume":"80","author":"Vos","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bbr.2016.05.030_bib0425","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0430","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neurobiolaging.2010.08.007","article-title":"Antemortem amyloid imaging and beta-amyloid pathology in a case with dementia with Lewy bodies","volume":"33","author":"Kantarci","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0435","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e3182231419","article-title":"Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease","volume":"77","author":"Ikonomovic","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.bbr.2016.05.030_bib0440","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2013.12.016","article-title":"Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer\u2019s disease","volume":"77","author":"Perez","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.05.030_bib0450","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2011.07.013","article-title":"Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer\u2019s disease","volume":"45","author":"Ginsberg","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2016.05.030_bib0455","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s00429-014-0839-0","article-title":"Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer\u2019s disease (AD)","volume":"220","author":"Alldred","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bbr.2016.05.030_bib0460","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2013.10.018","article-title":"Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment","volume":"79","author":"Counts","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0465","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-2010-101080","article-title":"Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer\u2019s disease","volume":"22","author":"Ginsberg","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0470","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchemneu.2011.05.012","article-title":"Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease","volume":"42","author":"Ginsberg","year":"2011","journal-title":"J. Chem. Neuroanat."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0475","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","article-title":"Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease","volume":"179","author":"Vana","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0480","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2006.03784.x","article-title":"Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo","volume":"97","author":"Guillozet-Bongaarts","year":"2006","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.bbr.2016.05.030_bib0485","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","article-title":"Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome","volume":"25","author":"Cataldo","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"5543","key":"10.1016\/j.bbr.2016.05.030_bib0490","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Lagos-Quintana","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0495","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1750-3639.2007.00120.x","article-title":"MicroRNAs (miRNAs) in neurodegenerative diseases","volume":"18","author":"Nelson","year":"2008","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0500","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"Hebert","year":"2009","journal-title":"Trends Neurosci."},{"issue":"47","key":"10.1016\/j.bbr.2016.05.030_bib0505","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1523\/JNEUROSCI.3338-08.2008","article-title":"MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons","volume":"28","author":"Aschrafi","year":"2008","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0510","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2009.10.020","article-title":"MicroRNAs potentiate neural development","volume":"64","author":"Fineberg","year":"2009","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0515","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2009.05.029","article-title":"Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB","volume":"63","author":"Rajasethupathy","year":"2009","journal-title":"Neuron"},{"issue":"7074","key":"10.1016\/j.bbr.2016.05.030_bib0520","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature04367","article-title":"A brain-specific microRNA regulates dendritic spine development","volume":"439","author":"Schratt","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0525","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.bbr.2016.05.030_bib0530","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.bbr.2016.05.030_bib0535","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons","volume":"33","author":"Absalon","year":"2013","journal-title":"J. Neurosci."},{"issue":"20","key":"10.1016\/j.bbr.2016.05.030_bib0540","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","article-title":"Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration","volume":"19","author":"Hebert","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.bbr.2016.05.030_bib0545","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease","volume":"33","author":"Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J."},{"issue":"50","key":"10.1016\/j.bbr.2016.05.030_bib0550","doi-asserted-by":"crossref","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","article-title":"Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease","volume":"285","author":"Cui","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0555","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/WNR.0b013e32834f4eb4","article-title":"miRNA-155 upregulation and complement factor H deficits in Down\u2019s syndrome","volume":"23","author":"Li","year":"2012","journal-title":"Neuroreport"},{"issue":"14","key":"10.1016\/j.bbr.2016.05.030_bib0560","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/WNR.0b013e32833da51a","article-title":"Acyclovir or Abeta42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells","volume":"21","author":"Lukiw","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2016.05.030_bib0565","article-title":"Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment","author":"Weinberg","year":"2016","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0570","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(11)70013-8","article-title":"The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations","volume":"10","author":"Bonda","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0575","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0580","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0585","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archneur.63.1.38","article-title":"Neuropathologic substrate of mild cognitive impairment","volume":"63","author":"Markesbery","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0590","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.1999.7086","article-title":"Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment","volume":"158","author":"Mufson","year":"1999","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0595","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2014.11.001","article-title":"2014 Update of the Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception","volume":"11","author":"Weiner","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0600","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/joim.12482","article-title":"Clinical and biomarker profiling of prodromal Alzheimer\u2019s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a \u2018European ADNI study","volume":"279","author":"Galluzzi","year":"2016","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0605","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0610","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0615","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0620","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"Pt 5","key":"10.1016\/j.bbr.2016.05.030_bib0625","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Alzheimer\u2019s Disease Neuroimaging, Association of brain amyloid-beta with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2016.05.030_bib0630","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3233\/JAD-2012-120292","article-title":"Assessment of Alzheimer\u2019s disease risk with functional magnetic resonance imaging: an arterial spin labeling study","volume":"31","author":"Bangen","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0635","first-page":"417","article-title":"Biodistribution and metabolism of [N-methyl-11C]m-hydroxyephedrine in the rat","volume":"24","author":"Law","year":"1997","journal-title":"Nucl. Med. Biol."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0640","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0197-4580(95)00052-G","article-title":"3rd, Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution","volume":"16","author":"Levine","year":"1995","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0645","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0650","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","article-title":"Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report","volume":"64","author":"Bacskai","year":"2007","journal-title":"Arch. Neurol."},{"issue":"Pt 6","key":"10.1016\/j.bbr.2016.05.030_bib0655","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0660","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.23633","article-title":"Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease","volume":"72","author":"Niedowicz","year":"2012","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0665","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2012-120655","article-title":"Postmortem Pittsburgh compound B (PiB) binding increases with Alzheimer\u2019s disease progression","volume":"32","author":"Beckett","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0670","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00401-012-0943-2","article-title":"Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study","volume":"123","author":"Ikonomovic","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.bbr.2016.05.030_bib0675","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease","volume":"55","author":"Haroutunian","year":"1998","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0680","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0685","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ana.23797","article-title":"In vivo assessment of amyloid-beta deposition in nondemented very elderly subjects","volume":"73","author":"Mathis","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0690","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"issue":"20","key":"10.1016\/j.bbr.2016.05.030_bib0695","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0700","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","article-title":"Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","volume":"72","author":"Curtis","year":"2015","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0705","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0710","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40120-014-0022-9","article-title":"Florbetaben for PET imaging of beta-amyloid plaques in the brain","volume":"3","author":"Richards","year":"2014","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.bbr.2016.05.030_bib0715","doi-asserted-by":"crossref","DOI":"10.1177\/1536012115624920","article-title":"Comparison of new tau PET-Tracer candidates with [18F]T808 and [18F]T807","volume":"15","author":"Declercq","year":"2016","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.bbr.2016.05.030_bib0720","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.conb.2015.09.002","article-title":"Tau imaging in the study of ageing, Alzheimer\u2019s disease, and other neurodegenerative conditions","volume":"36","author":"Villemagne","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"issue":"52","key":"10.1016\/j.bbr.2016.05.030_bib0725","doi-asserted-by":"crossref","first-page":"E5605","DOI":"10.1073\/pnas.1421311112","article-title":"Questionable evidence of natural warming of the northwestern United States","volume":"111","author":"Abatzoglou","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0730","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00259-012-2261-2","article-title":"Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer\u2019s disease pathology","volume":"40","author":"Harada","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0735","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00259-013-2681-7","article-title":"In vivo evaluation of a novel tau imaging tracer for Alzheimer\u2019s disease","volume":"41","author":"Villemagne","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbr.2016.05.030_bib0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-015-0220-4","article-title":"Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue","volume":"3","author":"Lemoine","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2016.05.030_bib0745","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-016-3363-z","article-title":"Imaging in-vivo tau pathology in Alzheimer\u2019s disease with THK5317 PET in a multimodal paradigm","author":"Chiotis","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0750","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","article-title":"Tau PET imaging in Alzheimer\u2019s disease","volume":"14","author":"Okamura","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"8","key":"10.1016\/j.bbr.2016.05.030_bib0755","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0760","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0765","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0770","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.bbr.2016.05.030_bib0775","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.bbr.2016.05.030_bib0780","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"39","author":"Schwarz","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0785","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann. Neurol."},{"issue":"25","key":"10.1016\/j.bbr.2016.05.030_bib0790","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.bbr.2016.05.030_bib0795","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer\u2019s disease","volume":"21","author":"Agdeppa","year":"2001","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2016.05.030_bib0800","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroimage.2008.07.022","article-title":"Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"43","author":"Shin","year":"2008","journal-title":"Neuroimage"},{"issue":"24","key":"10.1016\/j.bbr.2016.05.030_bib0805","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e3181c679cc","article-title":"Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment","volume":"73","author":"Tolboom","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0810","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F.]T.807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0815","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00401-012-0943-2","article-title":"Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study","volume":"123","author":"Ikonomovic","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0820","doi-asserted-by":"crossref","first-page":"e64971","DOI":"10.1371\/journal.pone.0064971","article-title":"Inflammatory proteins in plasma are associated with severity of Alzheimer\u2019s disease","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0825","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5\u201310 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0830","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"issue":"8\u20139","key":"10.1016\/j.bbr.2016.05.030_bib0835","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer\u2019s disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0840","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biopsych.2009.09.012","article-title":"Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer\u2019s disease","volume":"67","author":"Hinrichs","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0845","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta amyloid in Alzheimer\u2019s disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","volume":"65","author":"Grimmer","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0850","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.bbr.2016.05.030_bib0855","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"Pt 7","key":"10.1016\/j.bbr.2016.05.030_bib0860","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/brain\/awn107","article-title":"PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer\u2019s disease","volume":"131","author":"Koivunen","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bbr.2016.05.030_bib0865","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbr.2016.05.030_bib0870","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer\u2019s disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.bbr.2016.05.030_bib0875","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbr.2016.05.030_bib0880","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnagi.2014.00047","article-title":"Meta-Review of CSF core biomarkers in alzheimer\u2019s disease: the state-of-the-art after the new revised diagnostic criteria","volume":"6","author":"Ferreira","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2016.05.030_bib0885","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1192\/bjp.bp.114.160804","article-title":"An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer\u2019s disease according to presence of medial temporal lobe atrophy","volume":"208","author":"Firbank","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.bbr.2016.05.030_bib0890","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.neurobiolaging.2011.09.003","article-title":"CSF biomarkers for Alzheimer\u2019s disease: current utility and potential future use","volume":"32","author":"Holtzman","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.bbr.2016.05.030_bib0895","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.neurobiolaging.2011.11.029","article-title":"Toward a multifactorial model of Alzheimer disease","volume":"33","author":"Storandt","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0900","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","article-title":"Increased proNGF levels in subjects with mild cognitive impairment and mild alzheimer\u2019s disease","volume":"63","author":"Peng","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0905","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","article-title":"Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease","volume":"63","author":"Peng","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.bbr.2016.05.030_bib0910","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/NEN.0b013e318272caab","article-title":"Hippocampal proNGF signaling pathways and beta-amyloid levels in mild cognitive impairment and Alzheimer disease","volume":"71","author":"Mufson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbr.2016.05.030_bib0915","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2174\/1567205013666160129095649","article-title":"Cerebrospinal fluid proNGF: a putative biomarker for early Alzheimer\u2019s disease","volume":"13","author":"Counts","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2016.05.030_bib0920","series-title":"The Structure of Scientific Revolutions","author":"Kuhn","year":"1962"},{"issue":"6","key":"10.1016\/j.bbr.2016.05.030_bib0925","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2016.05.030_bib0930","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","article-title":"Braak staging, plaque pathology and APOE status in elderly persons without cognitive impairment","volume":"37","author":"Mufson","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2016.05.030_bib0935","unstructured":"[New perspectives for Alzheimer patients acetylcholine inhibition with Rivastigmine. Congress of the European Neurologic Society. Nice 6 July 199], Deutsche medizinische Wochenschrift 123(48 Suppl.) (1998) 1\u20134"},{"key":"10.1016\/j.bbr.2016.05.030_bib0940","first-page":"147","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"37","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816303059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816303059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T13:12:20Z","timestamp":1567861940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816303059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":188,"alternative-id":["S0166432816303059"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.05.030","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and cellular pathophysiology of preclinical Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}